Trials / Completed
CompletedNCT03280303
Palbociclib in Real World Practice
POLARIS: PALBOCICLIB IN HORMONE RECEPTOR POSITIVE ADVANCED BREAST CANCER: A PROSPECTIVE MULTICENTER NON-INTERVENTIONAL STUDY
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,285 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This Non-Interventional Study will describe and analyze the clinical use of palbociclib in routine clinical practice in the treatment of advanced breast cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | non-interventional |
Timeline
- Start date
- 2017-01-04
- Primary completion
- 2022-10-01
- Completion
- 2022-12-22
- First posted
- 2017-09-12
- Last updated
- 2024-09-20
- Results posted
- 2024-09-20
Locations
305 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT03280303. Inclusion in this directory is not an endorsement.